This competitive renewal application is for continued funding to investigate the molecular mechanisms underlying the anticancer effects of apigenin on prostate cancer. During the previous funding period, we investigated the effects of apigenin on various protein kinases, the IGF-I growth axis, ?-Catenin and NF-(B signaling pathways in cell cultures, tumor xenografts and a genetically-modified mouse model of prostate cancer. We found that apigenin inhibits multiple signal transduction pathways;consequently, potential targets of apigenin action include phosphatidylinositol 3-kinase (PI3K), protein kinase B/Akt, classical MAPK/ERK1/2, and cyclin-dependent kinases. The dose range of apigenin that effectively inhibits these targets is similar to that which suppresses signaling and prostate tumorigenesis and is physiologically attainable in humans. In this renewal application, we hypothesize that I(B kinase: IKKa/? acts as a central hub in mediating the anticancer effects of apigenin on multiple signal transduction pathways. Our hypothesis is based upon our previously published findings and our preliminary data showing that i) IKK activity is upregulated in human prostate cancer and its putative precursor ii) apigenin inhibits IKK activity and its phosphorylation, iii) apigenin inhibits multiple signal transduction pathways, specifically, the IGF-I axis, PI3K-Akt, NF-(B and ?-Catenin pathways, and iv) the IKK complex exhibits regulatory effects on all of these distinct signaling pathways. To test this hypothesis, we will use state-of-the-art techniques, including 1H NMR, X-ray crystallography, and advanced molecular biology procedures, and our studies will be performed on knock-in and knockout cell cultures and on transgenic (TRAMP) mice. Our proposed specific aims include investigation of i) the role of IKKa/? in cell transformation and the inhibitory activity of apigenin, ii) the role of IKKa on maspin suppression and its modulation by apigenin, iii) the role of IKK? on activity and cellular distribution of forkhead box O3a and its modulation by apigenin, and iv) IKKa/? as a molecular target for the anticancer effects of apigenin in vivo on TRAMP mice. We expect that understanding the molecular mechanisms underlying the anti-cancerous effects of apigenin may be helpful in developing effective chemopreventive/therapeutic strategies based upon targeting these key molecular mechanisms more effectively and with fewer associated side-effects.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Perloff, Marjorie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
Schools of Medicine
United States
Zip Code
Babcook, Melissa A; Shukla, Sanjeev; Fu, Pingfu et al. (2014) Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther 13:2288-302
Sharma, Haripaul; Kanwal, Rajnee; Bhaskaran, Natarajan et al. (2014) Plant flavone apigenin binds to nucleic acid bases and reduces oxidative DNA damage in prostate epithelial cells. PLoS One 9:e91588
Shukla, Sanjeev; Bhaskaran, Natarajan; Babcook, Melissa A et al. (2014) Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis 35:452-60
Thakur, Vijay S; Deb, Gauri; Babcook, Melissa A et al. (2014) Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention. AAPS J 16:151-63
Kanwal, Rajnee; Pandey, Mitali; Bhaskaran, Natarajan et al. (2014) Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol Carcinog 53:8-18
Deb, Gauri; Singh, Anup Kumar; Gupta, Sanjay (2014) EZH2: not EZHY (easy) to deal. Mol Cancer Res 12:639-53
Shukla, Sanjeev; Fu, Pingfu; Gupta, Sanjay (2014) Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer. Apoptosis 19:883-94
Deb, Gauri; Thakur, Vijay S; Gupta, Sanjay (2013) Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond. Epigenetics 8:464-76
Shukla, Sanjeev; Bhaskaran, Natarajan; Maclennan, Gregory T et al. (2013) Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice. Prostate 73:1507-17
Bhaskaran, Natarajan; Srivastava, Janmejai K; Shukla, Sanjeev et al. (2013) Chamomile confers protection against hydrogen peroxide-induced toxicity through activation of Nrf2-mediated defense response. Phytother Res 27:118-25

Showing the most recent 10 out of 37 publications